Javad Akhtari
Overview
Explore the profile of Javad Akhtari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Assadpour S, Akhtari J, Shiran M
Caspian J Intern Med
. 2022 Feb;
13(1):90-99.
PMID: 35178213
Background: Sumatriptan is a routine medication in the treatment of migraine and cluster headache that is generally given by oral or parental routes. However, a substantial proportion of patients suffer...
12.
Assadpour S, Shiran M, Asadi P, Akhtari J, Sahebkar A
Biomed Res Int
. 2022 Jan;
2022:3692065.
PMID: 35075426
Sumatriptan (ST) is a commonly prescribed drug for treating migraine. The efficiency of several routes of ST administration has been investigated. Recently, the intranasal route with different delivery systems has...
13.
Soosaraei M, Hezarjaribi H, Fakhar M, Akhtari J, Zolfaghari Emameh R
Ann Parasitol
. 2021 Dec;
67(3):367-386.
PMID: 34953114
Leishmaniosis is caused by different species of Leishmania parasites. The available treatments for this disease have not provided strong consistent results yet. The weak response of current chemotherapeutics can be...
14.
Hezarjaribi H, Toluee E, Saberi R, Dadi Moghadam Y, Fakhar M, Akhtari J
J Parasit Dis
. 2021 Nov;
45(4):921-929.
PMID: 34789973
keratitis (AK) is a rare but serious infection of the eye and can lead to blindness. The effective and safe medical therapy remains unclear for AK until present. Antimicrobial activity...
15.
Asadi P, Mehravaran A, Soltanloo N, Abastabar M, Akhtari J
Curr Med Mycol
. 2021 Sep;
7(1):71-78.
PMID: 34553102
Cutaneous fungal infections are the fourth most common health problem, which involves approximately one billion people worldwide. Drug delivery to the skin seems to be the best choice for superficial...
16.
Khalifeh S, Khodamoradi M, Hajali V, Ghazvini H, Eliasy L, Kheradmand A, et al.
Galen Med J
. 2021 Sep;
8:e1182.
PMID: 34466469
Background: Methamphetamine (METH) as a synthetic psychostimulant is being increasingly recognized as a worldwide problem, which may induce memory impairment. On the other hand, it is well established that naloxone,...
17.
Gheybi F, Alavizadeh S, Rezayat S, Hatamipour M, Akhtari J, Faridi Majidi R, et al.
J Pharm Sci
. 2021 Aug;
110(12):3919-3928.
PMID: 34418455
The drug delivery systems improve the efficacy of chemotherapeutics through enhanced targeting and controlled release however, biological barriers of tumor microenvironment greatly impede the penetration of nanomedicine within the tumor....
18.
Doagooyan M, Alavizadeh S, Akhtari J, Sahebkar A, Kiade S, Kochesfahani P, et al.
Infect Disord Drug Targets
. 2021 Mar;
22(1):e220321192415.
PMID: 33749564
In late 2019, a report from China was published stating a disease with an unknown cause. After that, the outbreak of the COVID-19 caused a pandemic in the world. On...
19.
Mohammadi H, Nekobahr E, Akhtari J, Saeedi M, Akbari J, Fathi F
Toxicol Rep
. 2021 Mar;
8:331-336.
PMID: 33659189
Recent advances in the use of magnetite nanoparticles for biomedical applications have led to special attention to these nanoparticles. The unique properties of magnetite nanoparticles such as superparamagnetism, low toxicity,...
20.
Zakeritabar S, Jahanshahi M, Peyravi M, Akhtari J
J Environ Health Sci Eng
. 2020 Dec;
18(2):1151-1161.
PMID: 33312631
Cerium fluoride (CeF) nanoparticles (NPs) were synthesized and applied in polysulfone (PS) membrane fabricated by phase inversion method. The produced nanocomposite membranes (PS/CeF) with different contents of CeF3 NPS (0.25%,...